Skip to content
Search

Latest Stories

PSNC raise concerns on NHS ad campaign that encourages people to visit high-street pharmacy for minor illness

The Pharmaceutical Services Negotiating Committee (PSNC) has raised concerns over the NHS ad campaign highlighting how community pharmacies can support patients with non-health advice amidst the growing pressure on pharmacies.

It believes the campaign will only ‘worsen’ the pressure on pharmacies.


“It is always deeply concerning to see campaigns directing people to pharmacies without any regard for the pressures they are under: it is irresponsible and extremely unhelpful,” said PSNC Chief Executive Janet Morrison.

She called the campaign ‘particularly irritating’ just weeks after the committee rejected a series of proposals from NHS England and DHSC on relief measures to ease pressure on pharmacies as being totally inadequate.

“NHS England Board Members have noted the pressure on pharmacies – so why are their teams so often acting to make these pressures worse? We need to see a radical change in how NHS England treats pharmacies and we’re continuing to press for that via our influencing and campaigning work,” she added.

The NHS launched the new campaign on Monday (27 February) to highlight how high-street pharmacies can support patients with non-urgent health advice for minor conditions including coughs, aches and colds.

The move was followed after a new poll found that just one in five people aged 18-40 would visit their local pharmacy first for expert advice with a minor illness.

Chief pharmaceutical officer, David Webb, said: “Community pharmacies are right in the heart of local communities, and with pharmacists fully trained clinical professionals, they are the perfect place for anybody suffering from a minor illness to get expert advice.

“Pharmacies can offer the convenience of turn up on the day consultations and can help you get any care needed including over-the-counter-medicines. So whether suffering from a cough, earache, itchy eye, or any other minor illness, popping into your local pharmacy is a great way to nip an issue in the bud before it potentially worsens.”

YouTube star and community pharmacist Abraham Khadadi is supporting the latest campaigning, noting the convenience local pharmacies offer and the opportunity to speak with an experienced healthcare professional.

Advanced Clinical Practitioner Pharmacist and YouTuber, Abraham said: “I would encourage everyone to make use of their local pharmacy. They are such a convenient way to obtain health advice on minor illnesses and you can usually just walk-in and speak to a pharmacist straight away – you don’t even need an appointment.

“All pharmacists train for four years at university with an additional year on a placement – so you can trust us to give you the advice you need – or signpost you to another health service if necessary.”

In response to news that the NHS has launched a pharmacy ad campaign, Morrison said: “Community pharmacies are the obvious first port of call for healthcare advice and this is why a national, fully funded Pharmacy First service makes so much sense. But the service must be fully funded: community pharmacies are at breaking point and cannot continue to operate without a significant injection of extra funds. We are making this point to Government and the NHS on a daily basis.”

More For You

Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less